Login / Signup

A randomized, double-blind trial comparing 5-aminolaevulinic acid nanoemulsion with methyl 5-aminolaevulinate in daylight photodynamic therapy for actinic keratosis.

Rolf-Markus SzeimiesPiergiacomo Calzavara-Pinton
Published in: The British journal of dermatology (2019)
Keyphrases
  • phase iii
  • double blind
  • phase ii
  • study protocol
  • clinical trial
  • placebo controlled
  • open label
  • cancer therapy
  • randomized controlled trial
  • drug delivery